# Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age

> **NCT05140720** · NA · UNKNOWN · sponsor: **Vabiotech** · enrollment: 300 (estimated)

## Conditions studied

- Streptococcus Pneumonia
- Vaccine Preventable Disease

## Interventions

- **BIOLOGICAL:** PNEUMOSIL®

## Key facts

- **NCT ID:** NCT05140720
- **Lead sponsor:** Vabiotech
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-25
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-06-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05140720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05140720, "Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05140720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*